These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6131128)

  • 1. beta-Adrenergic antagonists with multiple pharmacophores: persistent blockade of receptors.
    Pitha J; Milecki J; Czajkowska T; Kusiak JW
    J Med Chem; 1983 Jan; 26(1):7-11. PubMed ID: 6131128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two beta-adrenergic pharmacophores on the same molecule. A set of agonist-antagonist combinations.
    Kusiak JW; Heja G; Pitha J
    Biochem Pharmacol; 1987 Jan; 36(2):269-75. PubMed ID: 2880591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoreceptor antagonists with multiple pharmacophores: persistent inhibition of rat heart adenylate cyclase.
    Kusiak JW; Pitha J
    J Auton Pharmacol; 1983 Sep; 3(3):195-201. PubMed ID: 6139383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding.
    Chang RS; Lotti VJ
    Life Sci; 1983 May; 32(22):2603-9. PubMed ID: 6134224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature dependence of [3H]dihydroalprenolol binding in rat myocardium.
    Winek R; Bhalla R
    Eur J Pharmacol; 1982 Jan; 77(2-3):89-94. PubMed ID: 6277664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of beta-adrenergic receptors in rat ovary.
    Laszlovszky I; Erdö SL
    Eur J Pharmacol; 1983 Dec; 96(1-2):101-4. PubMed ID: 6141056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regeneration of beta-adrenergic receptors in senescent rats: a study using an irreversible binding antagonist.
    Pitha J; Hughes BA; Kusiak JW; Dax EM; Baker SP
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4424-7. PubMed ID: 6126874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and beta 1-, beta 2-adrenergic receptor binding studies of 4-acylamino-substituted phenoxypropanolamine and 5-acylamino-substituted naphthyloxypropanolamine derivatives.
    Jindal DP; Coumar MS; Bruni G; Massarelli P
    Arzneimittelforschung; 2002; 52(9):654-63. PubMed ID: 12404879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo.
    Baker SP; Pitha J
    J Pharmacol Exp Ther; 1982 Feb; 220(2):247-51. PubMed ID: 6120224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites.
    Landi M; Bianchetti A; Croci T; Manara L
    Biochem Pharmacol; 1992 Aug; 44(4):665-72. PubMed ID: 1354964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of L-[propyl-2,3-3H]dihydroalprenolol by intact HeLa cells.
    Meier KE; Ruoho AE
    Biochim Biophys Acta; 1984 Jul; 804(3):331-40. PubMed ID: 6146352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]dihydroalprenolol binding in the rat brainstem.
    Stone EA; U'Prichard DC
    Eur J Pharmacol; 1981 Oct; 75(2-3):159-61. PubMed ID: 6119217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and binding to beta-adrenergic receptors of p-aminobenzyl analogues of practolol and atenolol.
    Jones GS; Bylund DB; Hanson RN
    J Pharm Sci; 1992 Apr; 81(4):397-8. PubMed ID: 1354250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterization of skeletal muscle beta-adrenergic receptors coupled to adenylate cyclase.
    Reddy NB; Engel WK
    Biochim Biophys Acta; 1979 Jul; 585(3):343-59. PubMed ID: 226166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and biodistribution of a 125I-labeled beta-adrenoceptor antagonist bearing a cardioselectivity-enhancing N-substituent.
    Hanson RN; Blumberg JB; Poddubiuk ZM; Davis MA; Holman BL
    Int J Appl Radiat Isot; 1981 Jun; 32(6):429-33. PubMed ID: 6114044
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding characteristics of [3H]dihydroalprenolol to beta-adrenergic receptors of rat brain: comparison with those of rat heart treated with neuraminidase.
    Tsuchihashi H; Sasaki M; Nagatomo T
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3972-6. PubMed ID: 3004753
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure and biological activity of (-)-[3H]dihydroalprenolol, a radioligand for studies of beta-adrenergic receptors.
    Randall MH; Altman LJ; Lefkowitz RJ
    J Med Chem; 1977 Aug; 20(8):1090-4. PubMed ID: 197238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for two specific affinity states of 3H-antagonist binding to cardiac beta-adrenergic receptors and influence of Gpp(NH)p.
    Lang PH; Lemmer B
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):341-60. PubMed ID: 2993385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Displacement of [3H]dihydroalprenolol binding from rat heart and lung by acebutolol, diacetolol and D-diacetolol.
    Pong SF; Tinkham CL
    J Pharm Pharmacol; 1983 Mar; 35(3):198-9. PubMed ID: 6132987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.